Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Targeting heart failure in Indigenous communities
Our funded study reveals inequitable COVID-19 rates from the start
Please join us for an ECHO webinar on Tuesday Mar 30, 2021 (11 am – 12 pm) featuring Tamer Mohamed (President & CEO, Aspect Biosystems). Tamer’s presentation entitled, “From Research to Commercialization: The Aspect Biosystems Journey to Bioprinted Therapeutics”, will feature an overview of Aspect Biosystems, its technologies and the story behind its success. Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics.
Please register in advance for this meeting:
https://us02web.zoom.us/meeting/register/tZAtduCuqz0uHtw_gtLxT7Gd52EwEeHRSjXW
After registering, you will receive a confirmation email containing information about joining the webinar.